Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
5 hedge funds and large institutions have $169K invested in Artelo Biosciences, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
2,716% more capital invested
Capital invested by funds: $6K → $169K (+$163K)
25% more funds holding
Funds holding: 4 → 5 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.77K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Verition Fund Management
Greenwich,
Connecticut
| $166K | – | – | – |
|
|
VF
2
Virtu Financial
New York
| $2K | +$1.77K | +19,027 | New |
|
|
AGM
3
Alpine Global Management
New York
| $1K | – | – | – |
|
ARTLW Hedge Fund Activity: Q2 2022 in Review
5 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2022, worth a combined $169K — up 2,716% from $6K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.77K.
- 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2022, up from 4 in Q1 2022.
- Funds reported $169K of Artelo Biosciences, Inc. Warrant stock for Q2 2022, up 2,716% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q2 2022 was Virtu Financial, an estimated $1.77K added.
Based on aggregated 13F filings for Q2 2022.